Compartilhar
Informação da revista
Conteúdo especial sobre o coronavírus SARS-CoV-2 (COVID-19) em Hematology, Transfusion and Cell Therapy
Comparison of characteristics and laboratory tests of COVID-19 hematological patients from France and Brazil during the pre-vaccination period: identification of prognostic profiles for survival
Lilith Faucheux, Lucas Bassolli de Oliveira Alves, Sylvie Chevret, Vanderson Rocha
10.1016/j.htct.2022.05.003
Hematol Transfus Cell Ther. 2023;45:306-16
Acesso de texto completo
Evaluation of lymphocyte count, T-cell subsets and neutrophil-to-lymphocyte ratio as early predictors for severity and outcome of COVID-19 disease–a report from a highly complex hospital in Brazil
Douglas Câmara de Oliveira, Beatriz Sanada Spiri, Yara Carolina Schluga, Julie Lilian Pimentel Justus, Francisco Diego Negrão Lopes Neto, Ana Paula de Azambuja
10.1016/j.htct.2022.05.007
Hematol Transfus Cell Ther. 2023;45:330-7
Acesso de texto completo
Autoimmune hemolytic anemia and COVID-19 vaccination
Jeremy W. Jacobs
10.1016/j.htct.2022.08.007
Hematol Transfus Cell Ther. 2023;45:410-1
Acesso de texto completo
Effects of therapeutic plasma exchange on a cohort of patients with severe coronavirus infection: real world evidence from Brazil
Paula Menezes Schiefferdecker, Iara Buselato Chen, Fernanda Bronzel Bher, Leonardo Klettenberg Aciolli, Geovana Bodanese, Lucas Miyake Okumura, Paulo Tadeu Rodrigues de Almeida
10.1016/j.htct.2023.01.004
Hematol Transfus Cell Ther. 2023;45 Supl 2:S148-52
Acesso de texto completo
Thrombotic thrombocytopenic purpura and mushroom-shaped red blood cells secondary to COVID-19: A case report
Tarcísio Silva Borborema, Joziele de Souza Lima, Júlio César Moreira Brito, Mitiko Murao, Rodrigo Siqueira-Batista
10.1016/j.htct.2023.01.001
Acesso de texto completo
Disponível online em 7 de Fevereiro de 2023
Coincidental or causal? A case report of acquired thrombotic thrombocytopenic purpura following mRNA-1273 Covid-19 vaccination
Erinie M Mekheal, Christopher Millet, Nader Mekheal, Moutaz Ghrewati, Ashesha Mechineni, Michael Maroules
10.1016/j.htct.2022.09.1278
Acesso de texto completo
Disponível online em 22 de Janeiro de 2023
EFFICACY AND SAFETY OF NIPOCALIMAB, AN FCRN BLOCKER, IN WARM AUTOIMMUNE HEMOLYTIC ANEMIA (WAIHA): ENERGY PHASE 2/3 STUDY DESIGN
I Murakhovskaya, B Fattizzo, D Cueto, AB Perdomo, M Jouvin
10.1016/j.htct.2022.09.019
Hematol Transfus Cell Ther. 2022;44 Supl 2:S11
Open access
A PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MITAPIVAT IN PATIENTS WITH SICKLE CELL DISEASE
KH Kuo, A Oluyadi, H Shao, S Morris, AU Zaidi, EJV Beers, SL Thein
10.1016/j.htct.2022.09.021
Hematol Transfus Cell Ther. 2022;44 Supl 2:S12-3
Open access
PIRTOBRUTINIB, A HIGHLY SELECTIVE, NON-COVALENT (REVERSIBLE) BTK INHIBITOR IN PREVIOUSLY TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS FROM THE PHASE 1/2 BRUIN STUDY
RRBN Presenter, N Shah, A Alencar, J Gerson, M Patel, W Jurczak, K Patel, A Mato, C Cheah, M Wang
10.1016/j.htct.2022.09.214
Hematol Transfus Cell Ther. 2022;44 Supl 2:S127
Open access
PIRTOBRUTINIB, A HIGHLY SELECTIVE, NON-COVALENT (REVERSIBLE) BTK INHIBITOR IN PREVIOUSLY TREATED CLL/SLL: UPDATED RESULTS FROM THE PHASE 1/2 BRUIN STUDY
RR Barreto, K Patel, C Coombs, N Shah, T Eyre, W Wierda, P Ghia, M Davids, W Jurczak, A Mato
10.1016/j.htct.2022.09.235
Hematol Transfus Cell Ther. 2022;44 Supl 2:S139-40
Open access
Conteúdo especial sobre COVID-19
- Anti-PF4 antibodies and their relationship with COVID infection
- Extracellular vesicles are a late marker of inflammation, hypercoagulability and COVID-19 severity
- Thrombocytopenic thrombotic purpura related to COVID-19 vaccine: apropos of 4 cases
- Spontaneous remission without treatment of acute myelomonocytic leukemia associated with COVID-19 infection
Publicar em
Hematology, Transfusion and Cell Therapy
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.